| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.6 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |